Division of Hematology/Oncology, Department of Pediatrics, and.
Division of Hematology/Oncology, Department of Pediatrics, and Department of Biochemistry, University of Toronto, Program in Cell Biology, The Hospital for Sick Children, Toronto, ON, Canada.
Blood. 2014 Aug 14;124(7):1166-73. doi: 10.1182/blood-2014-04-570531. Epub 2014 Jun 23.
Despite its relatively estimated high occurrence, the characterization of pediatric upper extremity deep vein thrombosis (UE-DVT) and of UE postthrombotic syndrome (PTS) is still lacking. We investigated the occurrence, characteristics, and predictors of UE-PTS in a cohort of children with objectively confirmed UE-DVT. Patients were analyzed in 3 groups according to DVT pathogenesis and neonatal status: primary (G1), secondary neonates (G2neonates), and non-neonates (G2non-neonates). A total of 158 children (23 G1, 25 G2neonates, and 110 G2non-neonates) were included. The most common triggering factors were effort-related (87%) in G1 and central lines in G2neonates (100%) and in G2non-neonates (92%). PTS scores ≥1, as per the Modified Villalta Scale, were identified in 87% of primary patients, 16% of G2neonates, and 49% of G2non-neonates. Survival analysis showed that the time to PTS score ≥1 significantly differed among group (log-rank test P < .0001). A multivariable logistic regression showed that DVT pathogenesis and imaging-determined degree of thrombus resolution at the end of therapy were independent predictors of a PTS score ≥2. In conclusion, pediatric UE-PTS frequency and severity depend on UE-DVT pathogenesis (primary/secondary) and, within the secondary group, on patient's age. Line-related UE-PTS has a more benign course, particularly in neonates.
尽管小儿上肢深静脉血栓形成(UE-DVT)和 UE 血栓后综合征(PTS)的发病率相对较高,但对其特征的描述仍不够充分。我们调查了一组经客观证实的 UE-DVT 患儿中 UE-PTS 的发生、特征和预测因素。根据 DVT 发病机制和新生儿情况,将患者分为 3 组:原发性(G1)、新生儿继发性(G2neonates)和非新生儿(G2non-neonates)。共纳入 158 例患儿(23 例 G1、25 例 G2neonates 和 110 例 G2non-neonates)。最常见的触发因素是原发性患儿的与活动相关的(87%),新生儿继发性和非新生儿继发性的中心静脉置管(100%和 92%)。根据改良 Villalta 量表,87%的原发性患儿、16%的新生儿继发性患儿和 49%的非新生儿继发性患儿 PTS 评分≥1。生存分析显示,各组 PTS 评分≥1 的时间存在显著差异(对数秩检验 P<0.0001)。多变量逻辑回归显示,DVT 发病机制和治疗结束时影像学确定的血栓溶解程度是 PTS 评分≥2 的独立预测因素。总之,小儿 UE-PTS 的频率和严重程度取决于 UE-DVT 的发病机制(原发性/继发性),而在继发性组中,还取决于患者的年龄。与导管相关的 UE-PTS 具有更良性的病程,特别是在新生儿中。